Gene electrotransfer of plasmid antiangiogenic metargidin peptide (AMEP) in disseminated melanoma: safety and efficacy results of a phase I first-in-man study.
Spanggaard, Iben
Gene electrotransfer of plasmid antiangiogenic metargidin peptide (AMEP) in disseminated melanoma: safety and efficacy results of a phase I first-in-man study. [electronic resource] - Human gene therapy. Clinical development Sep 2013 - 99-107 p. digital
Publication Type: Clinical Trial, Phase I; Controlled Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
2324-8645
10.1089/humc.2012.240 doi
ADAM Proteins--chemistry
Aged
Angiogenesis Inhibitors--chemistry
Electroporation
Female
Genetic Therapy--adverse effects
Humans
Male
Melanoma--therapy
Membrane Proteins--chemistry
Middle Aged
Plasmids--genetics
Protein Structure, Tertiary--genetics
RNA, Messenger--metabolism
Skin Neoplasms--therapy
Transfection--methods
Treatment Outcome
Gene electrotransfer of plasmid antiangiogenic metargidin peptide (AMEP) in disseminated melanoma: safety and efficacy results of a phase I first-in-man study. [electronic resource] - Human gene therapy. Clinical development Sep 2013 - 99-107 p. digital
Publication Type: Clinical Trial, Phase I; Controlled Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
2324-8645
10.1089/humc.2012.240 doi
ADAM Proteins--chemistry
Aged
Angiogenesis Inhibitors--chemistry
Electroporation
Female
Genetic Therapy--adverse effects
Humans
Male
Melanoma--therapy
Membrane Proteins--chemistry
Middle Aged
Plasmids--genetics
Protein Structure, Tertiary--genetics
RNA, Messenger--metabolism
Skin Neoplasms--therapy
Transfection--methods
Treatment Outcome